This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Launches New Open Access Journal: Translational Proteomics

GENEVA, Switzerland, May 27, 2013 /PRNewswire/ --

First articles now available online on ScienceDirect

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Translational Proteomics, an online-only, open access journal devoted to transferring fundamental discoveries in the field of proteomics to clinical applications, accelerating understanding and treatment of human diseases.

Jean-Charles Sanchez, Associate Professor at the University of Geneva, Head of the Biomedical Research Proteomics Group and Director of the Proteomics Core Facility of the Faculty of Medicine, will serve as Editor-in-Chief. The journal aims to cover all areas of research in human proteomics using multi-disciplinary approaches to untangle complex disease processes, such as oncology, neurology, immunology, cardiovascular diseases, infectious diseases and any internal medical disorder. Special sections within the journal will highlight research in areas like systems biology and integrative bioinformatics, clinical proteomics and personalized medicine, comparative proteomics and drug development, medical bioinformatics and biostatistics, food and health.

"With the launch of Translational Proteomics, we want to help the scientific and medical communities overcome the challenges they face on the long path from basic research to patient care," said Professor Sanchez. "By focusing on connecting basic proteomics research to ultimate clinical applications, the journal will provide a space for publications detailing proteomics experiments, from early discovery to validation and the bedside."

"We are excited about the launch of Translational Proteomics", added Dolors Alsina, Executive Publisher at Elsevier. "This journal provides a unique platform for the publication of high-quality, multi-disciplinary studies, combining research which, until now, would have been broken into two or more specialized publications."

For more information or to submit an article, visit http://www.elsevier.com/locate/trprot

Open Access Publishing at Elsevier

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs